55919-47-6

Basic information

• Product Name: Ethyl 2-bromo-3-oxo-3-phenylpropanoate
• Synonyms: ETHYL 2-BROMO-3-OXO-3-PHENYLPROPANOATE;Ethyl 2-bromo-3-oxo-3-phenylpropionate, Ethyl benzoyl(bromo)acetate
• CAS NO: 55919-47-6
• Molecular Formula: C₁₁H₁₁BrO₃
• Molecular Weight: 271.11
• Mol File: 55919-47-6.mol
• Article Data: 56

Chemical Properties

• Boiling Point: 300.4 °C at 760 mmHg
• Flash Point: 135.5 °C
• Appearance: /
• Density: 1.445 g/cm³
• Vapor Pressure: 0.00112mmHg at 25°C
• Refractive Index: 1.548
• PKA: 7.09±0.26(Predicted)
• CAS DataBase Reference: Ethyl 2-bromo-3-oxo-3-phenylpropanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 2-bromo-3-oxo-3-phenylpropanoate(55919-47-6)
• EPA Substance Registry System: Ethyl 2-bromo-3-oxo-3-phenylpropanoate(55919-47-6)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 55919-47-6(Hazardous Substances Data)

Usage

General Description

Ethyl 2-bromo-3-oxo-3-phenylpropanoate is an organic compound that belongs to the class of esters. It is a colorless liquid with a fruity odor and is commonly used as a chemical intermediate in the synthesis of pharmaceuticals and other organic compounds. Ethyl 2-bromo-3-oxo-3-phenylpropanoate is also used as a reagent in organic reactions due to its high reactivity. Ethyl 2-bromo-3-oxo-3-phenylpropanoate is a versatile chemical that has applications in various industries such as pharmaceuticals, agrochemicals, and flavors and fragrances. However, it is important to handle this compound with care as it is corrosive and may cause irritation to the skin, eyes, and respiratory system.

InChI:InChI=1/C11H11BrO3/c1-2-15-11(14)9(12)10(13)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3

Upstream product

• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 128-08-5 N-Bromosuccinimide 
• 64-19-7 acetic acid 
• 4086-63-9 2-Benzylamino-6-aminotriazine 
• 98-86-2 acetophenone 
• 934-32-7 1H-benzimidazol-2-amine 
• 504-29-0 2-aminopyridine 
• 5764-85-2 Ethyl 3-hydroxy-3-phenylpropanoate 

Downstream Products

• 860744-60-1 3-oxo-3-phenyl-2,2-dipiperidino-propionic acid ethyl ester 
• 94-02-0 ethyl 3-oxo-3-phenylpropionate 
• 71-43-2 benzene 
• 60312-24-5 PL-158 
• 127801-93-8 ethyl 6-phenylimidazo<2,1-b>thiazole-5-carboxylate 
• 127801-97-2 ethyl 2-benzoylimino-2,3-dihydrothiazole-3-acetate 
• 127801-89-2 ethyl 2-phenylimidazo<1,2-a>pyrimidine-3-carboxylate 
• 144294-13-3 ethyl 2-phenylimidazo<1,2-a>pyrazine-3-carboxylate 
• 87814-40-2 N-(pyrazin-2-yl)benzamide 
• 127801-87-0 ethyl 6-methyl-2-phenylimidazo[1,2-a]pyridine-3-carboxylate 
• 127801-92-7 ethyl 3-methyl-6-phenylimidazo<2,1-b>thiazole-5-carboxylate 
• 127801-96-1 ethyl 2-benzoylimino-2,3-dihydro-4-methylthiazole-3-acetate 
• 127801-90-5 ethyl 7-methyl-2-phenylimidazo<1,2-a>pyrimidine-3-carboxylate 
• 127801-95-0 ethyl 7-ethoxy-2-phenylimidazo<2,1-b>benzothiazole-3-carboxylate 

Relevant articles and documents

Electrochemical chlorination and bromination of electron-deficient C[sbnd]H bonds in quinones, coumarins, quinoxalines and 1,3-diketones

The electrochemistry-promoted chlorination and bromination of electron-deficient C[sbnd]H bonds was developed, using quinones, coumarins, quinoxalines and 1,3-diketones. This protocol features readily available and safe halogen sources (hydrochloric acid and KBr), high site-selectivity and mild reaction conditions. It could provide an efficient access to a series of chlorinated and brominated quinones, coumarins, quinoxalines and 1,3-diketones.

PYRAZOLE AND IMIDAZOLE DERIVATIVES, COMPOSITIONS AND METHODS AS OREXIN ANTAGONISTS

The present invention is directed to substituted Pyrazole and Imidazole derivatives of compounds that are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which

Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents

Tuberculosis (TB) is a highly infectious disease that has been plaguing the human race for centuries. The emergence of multidrug-resistant strains of TB has been detrimental to the fight against tuberculosis with very few safe therapeutic options availabl